Claes Thulin leaving BioPhausia
16-Feb-2010
- Sweden
Mr. Thulin has offered to stay on as CEO until a successor is in place.
"After eight years as CEO I want to try something different, and intend to pursue entrepreneurial activities in the area of pharmaceuticals," he explains.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.